The Latest Trends On Clinical Pathways In Oncology
Cancer is a leading cause of death worldwide and remains a significant public health concern. Clinical pathways are a tool to help healthcare providers deliver high-quality, evidence-based care to patients with cancer. In recent years, there have been several trends in the development and use of clinical pathways in oncology. Personalized Medicine Personalized medicine, also […]
How The Inflation Reduction Act Will Impact Oncology Stakeholders
The Inflation Reduction Act (IRA) was recently introduced in the United States Senate and aims to reduce healthcare costs by addressing rising drug prices. The proposed legislation has significant implications for oncology stakeholders, including patients, providers, payers, and pharmaceutical manufacturers. In this article, we will explore how the Inflation Reduction Act will impact these stakeholders […]